Clinical Trial

Gastric Pathophysiology in Diabetes

Study acronym: DiaFLIP
Recruiting
View on ClinicalTrials.gov →
Summary
This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated. For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-03.
Trial Details
NCT Number NCT06068114
Lead Sponsor Institute for Clinical and Experimental Medicine
Collaborators: Poliklinika Agel, Dopravni zdravotnictvi a.s.
Conditions Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Functional Dyspepsia, Gastroparesis, Healthy
Enrollment 120 participants
Start Date 2022-10-05
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-17